Intervention Review

You have free access to this content

Vitamin A and fish oils for retinitis pigmentosa

  1. Sobharani Rayapudi1,
  2. Stephen G Schwartz2,*,
  3. Xue Wang1,
  4. Pamela Chavis3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 19 DEC 2013

Assessed as up-to-date: 20 AUG 2013

DOI: 10.1002/14651858.CD008428.pub2


How to Cite

Rayapudi S, Schwartz SG, Wang X, Chavis P. Vitamin A and fish oils for retinitis pigmentosa. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD008428. DOI: 10.1002/14651858.CD008428.pub2.

Author Information

  1. 1

    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, Maryland, USA

  2. 2

    Bascom Palmer Eye Institute, Miami, Florida, USA

  3. 3

    Medical University of South Carolina, Department of Ophthalmology, Charleston, South Carolina, USA

*Stephen G Schwartz, Bascom Palmer Eye Institute, Miami, Florida, USA. sschwartz2@med.miami.edu.

Publication History

  1. Publication Status: New
  2. Published Online: 19 DEC 2013

SEARCH

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Berson 1993 {published data only}
  • Berson EL, Rosner B, Sandberg MA, Hayes KC, Nicholson BW, Weigel-DiFranco C, et al. A randomized trial of vitamin A and vitamin E supplementation for retinitis pigmentosa. Archives of Ophthalmology 1993;111(6):761-72.
Berson 2004a {published data only}
  • Berson EL, Rosner B, Sandberg MA, Hayes KC, Weigel-DiFranco C, Moser A, et al. Clinical trial of Docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment. Archives of Ophthalmology 2004;122(9):1297-1305.
  • Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al. Further evaluation of docosahexaenoic acid inpatients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Archives of Ophthalmology 2004;122(9):1306-14.
Hoffman 2004 {published data only}
  • Hoffman DR, Locke KG, Wheaton DH, Fish GE, Spencer R, Birch DG. A randomized, placebo-controlled clinical trial of docosahexaenoic acid supplementation for X-linked retinitis pigmentosa. American Journal of Ophthalmology 2004;137(4):704-18.

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Bergsma 1977 {published data only}
  • Bergsma DR, Wolf ML. A therapeutic trial of vitamin A in patients with pigmentary retinal degenerations: a negative study. Advances in Experimental Medicine and Biology 1977;77:197-209.
Berson 2010 {published data only}
  • Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Brockhurst RJ, Hayes KC, et al. Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin A. Archives of Ophthalmology 2010;128(4):403-11.
Dagnelie 2000 {published data only}
  • Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry 2000;71(3):147-64.
Fex 1996 {published data only}
  • Fex GA, Andréasson S, Ehinger B. Serum retinoids in retinitis pigmentosa patients treated with vitamin A. Graefe's Archive for Clinical and Experimental Ophthalmology 1996;234(Suppl 1):S18-21.
Sibulesky 1999 {published data only}
  • Sibulesky L, Hayes KC, Pronczuk A, Weigel-DiFranco C, Rosner B, Berson EL. Safety of <7500 RE (<25000 IU) vitamin A daily in adults with retinitis pigmentosa. American Journal of Clinical Nutrition 1999;69(4):656-63.
Tcherkes 1950 {published data only}
  • Tcherkes LA, Averbach IM, Iakovleva SP. Use of vitamin A in retinitis pigmentosa. Vjestnik Oftalmologyi 1950;29(1):33-40.
Wheaton 2003 {published data only}
  • Wheaton DH, Hoffman DR, Locke KG, Watkins RB, Birch DG. Biological safety assessment of docosahexaenoic acid supplementation in a randomized clinical trial for X-linked retinitis pigmentosa. Archives of Ophthalmology 2003;121(9):1269-78.

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Anderson 1989
Berson 1969
Berson 1982
Berson 1985
Berson 2004b
  • Berson EL, Rosner B, Sandberg MA, Weigel-DiFranco C, Moser A, Brockhurst RJ, et al. Further evaluation of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment: subgroup analyses. Archives of Ophthalmology 2004;122(9):1306-14.
Birch 2005
  • Birch DG. A randomized placebo-controlled clinical trial of docosahexaenoic acid (DHA) supplementation for X-linked retinitis pigmentosa. Retina 2005;25(Suppl 8):S52-4.
Borly 2001
  • Borly L, Wille-Jorgensen P, Rasmussen MS, Andersen BR. Problems with retrieving original data: is it a selection bias?. 9th Annual Cochrane Colloquium; 2001 Oct 9-13; Lyon, France. 2001.
Chen 1996
  • Chen Y, Houghton LA, Brenna JT, Noy N. Docosahexaenoic acid modulates the interactions of the interphotoreceptor retinoid-binding protein with 11-cis-retinal. Journal of Biological Chemistry 1996;271(34):20507-15.
Daiger 2007
Dowling 1960
Flynn 2001
Glanville 2006
  • Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
Hartong 2006
Higgins 2011a
  • Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Higgins 2011b
  • Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
Hodge 2005
  • Hodge W, Barnes D, Schachter HM, Pan Y, Lowcock EC, Zhang L, et al. Effects of omega-3 fatty acids on eye health. Evidence Report:Technology Assessment (Summary) 2005;117:1-6.
Holopigian 1996
Massof 2010
  • Massof RW, Fishman GA. How strong is the evidence that nutritional supplements slow the progression of retinitis pigmentosa?. Archives of Ophthalmology 2010;128(4):493-5.
Norton 1993
Oishi 2009
  • Oishi A, Nakamura H, Tatsumi I, Sasahara M, Kojima H, Kurimoto M, et al. Optical coherence tomographic pattern and focal electroretinogram in patients with retinitis pigmentosa. Eye 2009;23(2):299-303.
RevMan 2012 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Walia 2007
Witkin 2006
  • Witkin AJ, Ko TH, Fujimoto JG, Chan A, Drexler W, Schuman JS, et al. Ultra-high resolution optical coherence tomography assessment of photoreceptors in retinitis pigmentosa and related diseases. American Journal of Ophthalmology 2006;142(6):945-52.

References to other published versions of this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. Additional references
  4. References to other published versions of this review
Rayapudi 2010
  • Rayapudi S, Schwartz SG, Chavis P. Vitamin A and fish oils for retinitis pigmentosa. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD008428]